Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) EPS (Weighted Average and Diluted) (2021 - 2022)

Historic EPS (Weighted Average and Diluted) for Catheter Precision (VTAK) over the last 2 years, with Q4 2022 value amounting to -$7.89.

  • Catheter Precision's EPS (Weighted Average and Diluted) rose 8664.63% to -$7.89 in Q4 2022 from the same period last year, while for Dec 2022 it was -$25.98, marking a year-over-year decrease of 21976.92%. This contributed to the annual value of -$25.98 for FY2022, which is 9037.4% up from last year.
  • According to the latest figures from Q4 2022, Catheter Precision's EPS (Weighted Average and Diluted) is -$7.89, which was up 8664.63% from -$4361.7 recorded in Q3 2022.
  • In the past 5 years, Catheter Precision's EPS (Weighted Average and Diluted) ranged from a high of -$1.28 in Q2 2021 and a low of -$4361.7 during Q3 2022